Cited by 139Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease

Alvarez, X. Antón, Franco, Andrés, Fernández-Novoa, Lucía, Cacabelos, Ramón·1996·Molecular and Chemical Neuropathology

Abstract

In this study, we have evaluated the levels of blood histamine, serum interleukin-1 beta (IL-1 beta), and plasma tumor necrosis factor-alpha (TNF-alpha) in 20 patients with mild to moderate Alzheimer disease (AD; 13 early onset and 7 late-onset AD subjects) and in 20 age-matched control subjects (C). AD patients showed higher concentrations of histamine (AD = 452.9 +/- 237.9 pmol/mL; C = 275.3 +/- 151.5 pmol/mL; p < 0.05) and IL-1 beta (AD = 211.2 +/- 31.1 pg/mL; C = 183.4 +/- 24.4 pg/mL; p < 0.01), and lower values of TNF-alpha (AD = 3.59 +/- 2.02 pg/mL; C = 9.47 +/- 2.64 pg/mL; p < 0.001) than elderly controls. Increased levels of histamine and decreased levels of TNF-alpha were observed in both early onset AD (EOAD) and late-onset AD (LOAD) patients, but only EOAD subjects had elevated serum IL-1 beta values compared with age-matched controls. Age negatively correlated with histamine (r = -0.57; p < 0.05) and positively with IL-1 beta levels (r = 0.48; p < 0.05) in healthy subjects, but not in AD, whereas a positive correlation between TNF-alpha scores and age was only found in AD patients (r = 0.46; p < 0.05). Furthermore, histamine and TNF-alpha values correlated negatively in AD (r = -0.50, p < 0.05). In addition, cognitive impairment increased in patients with lower TNF-alpha and higher histamine and IL-1 beta levels, as indicated by the correlations between mental performance scores and histamine (r = -0.37, ns), IL-1 beta (r = -0.33, ns) and TNF-alpha levels (r = 0.42, p < 0.05). Finally, histamine concentrations decreased as depression scores increased in AD (r = -0.63, p < 0.01). These data suggest a dysfunction in cytokine and histamine regulation in AD, probably indicating changes associated with inflammatory processes.

Integrity signals

Registry

Crossref · 10.1007/bf02815005

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Systemic inflammation is involved in the pathophysiology of neuropsychiatric diseases such as depression and schizophrenia as well as age-related cognitive decline.

    “In addition, there is growing experimental and clinical evidence implicating systemic inflammation to be involved in the pathophysiology of neuropsychiatric diseases such as depression and schizophrenia as well as age-related cognitive decline [7], [8], [9], [10], [11], [12], [13], [14].”

Cites

Flagged first, then by citations

1 of the 59 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Alvarez, X. A., Franco, A., Fernández-Novoa, L., & Cacabelos, R.
Affiliations
EuroEspes Biomedical Research Center (ES)
Venue
Molecular and Chemical Neuropathology
Published
1996-10
Volume
29
Issue
2-3
Pages
237-252
ISSN
1044-7393 (ISSN-L)
OpenAlex
W1978853688
Cited by
139
References
59
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 4
FWCI
1.83
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular and Chemical Neuropathology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, histamine, IL-1β, TNF-α, early-onset Alzheimer's disease, late-onset Alzheimer's disease, blood cytokines, cognitive impairment, depression, neuroinflammation, neuroprotection
MeSH terms
Aged, Alzheimer Disease, Cognition, Female, Histamine, Humans, Interleukin-1, Male, Middle Aged, Psychiatric Status Rating Scales, Reference Values, Tumor Necrosis Factor-alpha, Biomarkers, Age of Onset

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review